| Opella Healthcare Switzerland AG - Novalgin, Injektionslösung i.m., i.v. |
| 16950 | | 01 | | Novalgin | | Injektionslösung i.m., i.v. | | N02BB02 | | Metamizole Sodium | | 24.03.1982 | | |
|
| Composition |
| metamizolum natricum monohydricum 500 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Metamizolum Natricum Monohydricum | 500 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Metamizolum Natricum Monohydricum | 2500 mg |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 025 | 10 1 ampoule(s) à 2 ml | 3.49 | 13.05 | B | SL | Yes | | 068 | 5 1 ampoule(s) à 5 ml | 3.23 | 12.75 | B | SL | Yes |
|
